| Literature DB >> 35072404 |
Aleks Değirmencioğlu1, Gültekin Karakuş1, Ertuğrul Zencirci1, Ahmet Ümit Güllü2, Şahin Şenay2.
Abstract
INTRODUCTION: There are several approaches for pericardiocentesis. However, there is no definite suggestion about puncture location after cardiac surgery. The purpose of this study is to examine whether there is any difference regarding puncture location during pericardiocentesis in postoperative cardiac tamponade comparing to nonsurgical cardiac tamponade.Entities:
Keywords: Cardiac Tamponade; Cardiovascular Surgical Procedures; Drainage; Pericardiocentesis; Punctures
Mesh:
Year: 2022 PMID: 35072404 PMCID: PMC9423801 DOI: 10.21470/1678-9741-2020-0714
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Baseline clinic, echocardiographic, and laboratory characteristics of patients.
| Nonsurgical group (n= 41) | Postsurgical group (n=27) | ||
|---|---|---|---|
| Age (years) | 54.9±17.1 | 54.7±11.4 | 0.96 |
| Male [n, (%)] | 24 (58.5) | 21 (77.8) | 0.1 |
| Warfarin [n, (%)] | 0 (0) | 16 (59.3) | < 0.001 |
| Fluid distribution (loculated/circumferential) [n, (%)] | 2 (4.9)/39 (95.1) | 13 (48.1)/14 (51.9) | < 0.001 |
| Maximal fluid thickness (mm) | 30.7±9.7 | 33.8±8.2 | 0.21 |
| Maximal fluid location (apical/lateral/RV) [n, (%)] | 21 (51.2)/5 (12.2)/15 (36,6) | 13 (48.1)/11 (40.7)/3 (11.1) | 0.8/0.007/0.02 |
| CRP | 9.4±6.1 | 6.2±3.2 | 0.06 |
| Hemoglobin (g/dl) | 11.1±2.1 | 10.5±2.2 | 0.25 |
Procedural outcomes.
| Non-surgical group (n=41) | Postsurgical group (n=27) | ||
|---|---|---|---|
| Drainage location (apical/subxiphoid) [(n, %)] | 22 (53.7)/19 (46.3) | 21 (77.8)/6 (22.2) | 0.044 |
| Procedural success (n, %) | 39 (95.1) | 27 (100) | 0.51 |
| Appearance of effusion (serous/serohemorrhagic/hemorrhagic) [(n, %)] | 16 (39)/7 (17.1)/18 (43.9) | 5 (18.5)/9 (33.3)/13 (48.2) | 0.07/0.12/0.73 |
| Drainage volume (ml) | 974.9 ± 894.8 | 748.8 ± 333.2 | 0.52 |
| Duration of drainage (hour) | 33.1 ± 48.9 | 19.9 ± 19.9 | 0.21 |
| Minor complication (n, %) | 5 (12.2) | 0 (0) | 0.15 |
| Recurrence (n, %) | 4 (9.8) | 3 (11.1) | 0.99 |
| Emergency procedure (n, %) | 10 (24.4) | 5 (18.5) | 0.57 |
| In-hospital mortality (n, %) | 5 (12.2) | 0 (0) | 0.15 |
| Abbreviations, acronyms & symbols | |
|---|---|
| CRP | = C-reactive protein |
| RV | = Right ventricular |
| Authors' roles & responsibilities | |
|---|---|
| AD | Substantial contributions to the conception and design of the work; and the acquisition, analysis, and interpretation of data for the work; final approval of the version to be published |
| GK | Substantial contributions to the conception and design of the work; and the analysis and interpretation of data for the work; final approval of the version to be published |
| EZ | Substantial contributions to the acquisition and analysis of data for the work; final approval of the version to be published |
| AÜG | Substantial contributions to the acquisition of data for the work; final approval of the version to be published |
| ŞŞ | Revising the work; final approval of the version to be published |